$32.43
-2.70-7.69%
At close: -
$32.43
0.000.00%
After Hours: Apr 4, 4:00 PM EDT
Comments
Loading...
Ultragenyx Pharmaceutical Insider Trading Activity | NASDAQ:RARE | Benzinga
Track the latest Ultragenyx Pharmaceutical insider trading activity. Stay informed on recent buys, sells, and market impact for Ultragenyx Pharmaceutical stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Ultragenyx Pharmaceutical Inc Insiders Doing?
At Ultragenyx Pharmaceutical Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 1.79K shares worth $72.11K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 10, 2025, Howard Horn, the company's CHIEF FINANCIAL OFFICER sold 1.79K shares for $40.4 each.
Ownership Statistics for Ultragenyx Pharmaceutical Inc
Shares Outstanding
93.900M
Insider Shares Owned
2.020M
Insider Percentage Owned
2.15%
Institutional Shares Held
51.870M
Institutional Percentage Held
55.2%
| Mar 10, 2025 | Howard Horn | CHIEF FINANCIAL OFFICER | -1.78K | $40.40 | -$72.11K | SELL | -1.65% | 106.17K | Mar 06 | View |
| Mar 04, 2025 | Richard Thomas Kassberg | CBO & EVP | 11.91K | $42.16 | -$275.58K | GRANT | 4.71% | 264.73K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | 5.60K | $42.10 | -$540.82K | GRANT | 8.03% | 75.29K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Eric Crombez | EVP AND CHIEF MEDICAL OFFICER | 22.84K | $42.10 | -$376.58K | GRANT | 46.53% | 71.92K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Richard John Pinion | SEE REMARKS | 18.47K | $42.10 | -$609.21K | GRANT | 20.53% | 108.43K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | EMIL KAKKIS | PRESIDENT & CEO | 52.13K | $42.20 | -$4.15M | GRANT | 2.47% | 2.16M | Feb 28 - Mar 03 | View |
| Mar 04, 2025 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | 20.15K | $42.10 | -$635.84K | GRANT | 29.77% | 87.86K | Mar 01 - Mar 03 | View |
| Mar 04, 2025 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | 8.28K | $42.20 | -$46.76K | GRANT | 19.80% | 50.12K | Mar 01 - Mar 03 | View |
| Mar 03, 2025 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | 11.50K | $42.88 | -$128.22K | GRANT | 19.77% | 69.69K | Feb 27 - Mar 01 | View |
| Dec 31, 2024 | EMIL KAKKIS | PRESIDENT & CEO | -11.73K | $42.23 | -$495.23K | SELL | -0.42% | 2.75M | Dec 30 | View |
| Dec 11, 2024 | EMIL KAKKIS | PRESIDENT & CEO | -28.27K | $50.00 | -$413.65K | SELL | -1.01% | 2.76M | Dec 09 - Dec 10 | View |
| Oct 11, 2024 | Howard Horn | CHIEF FINANCIAL OFFICER | -7.46K | $52.76 | -$393.85K | SELL | -7.48% | 92.30K | Oct 10 | View |
| Sep 05, 2024 | EMIL KAKKIS | PRESIDENT & CEO | -20.00K | $55.85 | -$1.12M | SELL | -0.71% | 2.79M | Sep 03 | View |
| Sep 05, 2024 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -91.00 | $56.19 | -$5.11K | SELL | -0.22% | 41.55K | Sep 03 | View |
| Aug 07, 2024 | EMIL KAKKIS | PRESIDENT & CEO | -20.00K | $50.17 | -$1.00M | SELL | -0.71% | 2.81M | Aug 06 | View |
| Jul 03, 2024 | Corsee Corazon Sanders | — | -584.00 | $40.98 | -$23.93K | SELL | -4.64% | 12.01K | Jul 02 | View |
| Jun 12, 2024 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | -9.81K | $45.00 | -$441.27K | SELL | -14.47% | 57.98K | Jun 12 | View |
| Jun 10, 2024 | Corsee Corazon Sanders | — | -1.74K | $41.10 | -$71.39K | SELL | -19.33% | 7.25K | Jun 10 | View |
| May 03, 2024 | Eric Crombez | EVP AND CHIEF MEDICAL OFFICER | -354.00 | $43.66 | -$15.46K | SELL | -0.73% | 48.43K | May 02 | View |
| Apr 19, 2024 | Eric Crombez | EVP AND CHIEF MEDICAL OFFICER | -142.00 | $44.10 | -$6.26K | SELL | -0.29% | 48.78K | Apr 18 | View |
| Mar 12, 2024 | Richard Thomas Kassberg | CBO & EVP | -11.51K | $49.93 | -$574.64K | SELL | -4.35% | 252.82K | Mar 11 | View |
| Mar 11, 2024 | Matthew Fust | — | -12.20K | $50.88 | -$620.44K | SELL | -45.07% | 14.86K | Mar 07 | View |
| Mar 05, 2024 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | 15.00K | $53.76 | -$201.92K | GRANT | 28.66% | 67.34K | Mar 01 | View |
| Mar 05, 2024 | Richard Thomas Kassberg | CBO & EVP | 17.47K | $53.75 | -$69.06K | GRANT | 7.08% | 264.33K | Mar 01 | View |
| Mar 05, 2024 | Richard John Pinion | SEE REMARKS | 14.52K | $53.76 | -$227.56K | GRANT | 19.43% | 89.27K | Mar 01 | View |
| Mar 05, 2024 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | 13.49K | $53.74 | -$24.83K | GRANT | 48.36% | 41.38K | Mar 01 | View |
| Mar 05, 2024 | Eric Crombez | EVP AND CHIEF MEDICAL OFFICER | 18.16K | $53.76 | -$66.55K | GRANT | 59.03% | 48.93K | Mar 01 | View |
| Mar 05, 2024 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | 15.59K | $53.76 | -$256.33K | GRANT | 30.23% | 67.16K | Mar 01 | View |
| Feb 08, 2024 | EMIL KAKKIS | PRESIDENT & CEO | -30.00K | $45.00 | -$1.35M | SELL | -1.06% | 2.80M | Feb 07 | View |
| Jan 02, 2024 | EMIL KAKKIS | PRESIDENT & CEO | -30.00K | $47.87 | -$1.44M | SELL | -1.05% | 2.83M | Dec 29 | View |
| Oct 24, 2023 | Richard Thomas Kassberg | CBO & EVP | 0.00 | $19.82 | -$1.03M | SELL-OPTIONS | 0.00% | 246.86K | Oct 23 | View |
| Oct 23, 2023 | EMIL KAKKIS | PRESIDENT & CEO | 0.00 | $20.19 | -$1.28M | SELL-OPTIONS | 0.00% | 2.86M | Oct 19 | View |
| Sep 11, 2023 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -163.00 | $30.90 | -$46.25K | SELL | -0.69% | 23.61K | Sep 07 | View |
| Sep 06, 2023 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -6.00K | $37.96 | -$227.76K | SELL | -10.47% | 51.28K | Sep 05 | View |
| Sep 06, 2023 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -970.00 | $37.15 | -$36.03K | SELL | -3.92% | 23.78K | Sep 01 | View |
| Jun 30, 2023 | Corsee Corazon Sanders | DIRECTOR | -585.00 | $46.76 | -$27.35K | SELL | -6.11% | 8.98K | Jun 30 | View |
| Jun 21, 2023 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -305.00 | $48.20 | -$14.70K | SELL | -0.53% | 57.28K | Jun 19 | View |
| Jun 09, 2023 | Corsee Corazon Sanders | DIRECTOR | 2.38K | $51.65 | -$76.70K | GRANT | 33.01% | 9.57K | Jun 07 - Jun 08 | View |
| May 19, 2023 | Richard John Pinion | SEE REMARKS | -2.01K | $50.00 | -$100.60K | SELL | -2.62% | 74.74K | May 18 | View |
| May 05, 2023 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | -4.38K | $45.00 | -$197.01K | SELL | -7.77% | 51.98K | May 04 | View |
| Mar 03, 2023 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | -1.22K | $45.25 | -$175.62K | SELL | -2.54% | 46.72K | Mar 01 | View |
| Mar 03, 2023 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | 21.50K | $45.25 | -$143.04K | GRANT | 62.08% | 56.14K | Mar 01 | View |
| Mar 03, 2023 | Richard Thomas Kassberg | CBO & EVP | 19.30K | $45.51 | -$244.03K | ACQUISITION | 8.48% | 246.86K | Mar 01 | View |
| Mar 03, 2023 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | 6.16K | $45.65 | -$65.42K | ACQUISITION | 39.57% | 21.71K | Mar 01 | View |
| Mar 03, 2023 | Karl Dennis Huang | SEE REMARKS | 13.68K | $45.65 | -$501.60K | ACQUISITION | 26.79% | 64.72K | Mar 01 | View |
| Mar 03, 2023 | Richard John Pinion | SEE REMARKS | 16.89K | $45.46 | -$353.19K | ACQUISITION | 28.51% | 76.16K | Mar 01 | View |
| Mar 03, 2023 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | 21.00K | $45.25 | -$165.80K | GRANT | 57.78% | 57.34K | Mar 01 | View |
| Mar 02, 2023 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -639.00 | $43.40 | -$27.73K | SELL | -3.95% | 15.56K | Feb 28 | View |
| Jan 03, 2023 | EMIL KAKKIS | PRESIDENT & CEO | -19.58K | $45.57 | -$892.35K | SELL | -0.69% | 2.82M | Dec 30 | View |
| Dec 22, 2022 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -2.03K | $43.96 | -$89.28K | SELL | -11.14% | 16.20K | Dec 21 | View |
| Oct 17, 2022 | Mardi Dier | CFO & EXECUTIVE VICE PRESIDENT | -1.63K | $40.16 | -$65.42K | SELL | -2.38% | 66.69K | Oct 14 | View |
| Oct 14, 2022 | Mardi Dier | CFO & EXECUTIVE VICE PRESIDENT | -3.48K | $38.22 | -$133.16K | SELL | -4.85% | 68.32K | Oct 12 | View |
| Jun 22, 2022 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -295.00 | $54.78 | -$16.16K | SELL | -0.81% | 36.16K | Jun 19 | View |
| Apr 19, 2022 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -132.00 | $84.55 | -$11.16K | SELL | -0.77% | 16.91K | Apr 16 | View |
| Mar 15, 2022 | Richard Thomas Kassberg | CBO & EVP | -10.28K | $67.01 | -$688.93K | SELL | -4.32% | 227.56K | Mar 11 | View |
| Mar 08, 2022 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | -5.14K | $62.95 | -$323.56K | SELL | -12.99% | 34.44K | Mar 07 | View |
| Mar 03, 2022 | Mardi Dier | CFO & EXECUTIVE VICE PRESIDENT | 13.05K | $65.71 | -$62.69K | GRANT | 33.66% | 51.81K | Mar 01 - Mar 03 | View |
| Mar 03, 2022 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | 11.29K | $66.62 | -$180.74K | GRANT | 45.09% | 36.32K | Mar 01 | View |
| Mar 03, 2022 | Richard John Pinion | SEE REMARKS | 9.50K | $66.62 | -$299.66K | GRANT | 19.09% | 59.27K | Mar 01 | View |
| Mar 03, 2022 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | 2.87K | $66.62 | -$56.16K | GRANT | 20.22% | 17.05K | Mar 01 | View |
| Mar 03, 2022 | Karl Dennis Huang | SEE REMARKS | 10.77K | $66.62 | -$215.45K | GRANT | 26.73% | 51.04K | Mar 01 | View |
| Mar 03, 2022 | Karah Parschauer | EVP AND CHIEF LEGAL OFFICER | 11.11K | $66.62 | -$192.27K | GRANT | 39.05% | 39.58K | Mar 01 | View |
| Mar 03, 2022 | Richard Thomas Kassberg | CBO & EVP | 11.63K | $66.62 | -$158.16K | GRANT | 5.38% | 227.84K | Mar 01 | View |
| Mar 03, 2022 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | 11.18K | $66.62 | -$187.94K | GRANT | 30.41% | 47.94K | Mar 01 | View |
| Feb 01, 2022 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | -1.66K | $66.30 | -$109.86K | SELL | -4.31% | 36.76K | Jan 30 | View |
| Oct 18, 2021 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | -359.00 | $81.14 | -$29.13K | SELL | -0.93% | 38.42K | Oct 14 | View |
| Oct 18, 2021 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -303.00 | $81.14 | -$24.59K | SELL | -1.20% | 25.03K | Oct 14 | View |
| Oct 18, 2021 | Karl Dennis Huang | EVP & CHIEF TECH OPS OFFICER | -358.00 | $81.14 | -$29.05K | SELL | -0.88% | 40.15K | Oct 14 | View |
| Oct 18, 2021 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -959.00 | $81.14 | -$11.36K | SELL | -6.38% | 14.07K | Sep 13 - Oct 14 | View |
| Oct 18, 2021 | Richard Thomas Kassberg | CBO & EVP | -286.00 | $81.14 | -$23.21K | SELL | -0.13% | 216.27K | Oct 14 | View |
| Oct 18, 2021 | Karah Parschauer | EVP AND GENERAL COUNSEL | -310.00 | $81.14 | -$25.15K | SELL | -1.08% | 28.36K | Oct 14 | View |
| Oct 18, 2021 | Richard John Pinion | SEE REMARKS | -358.00 | $81.14 | -$29.05K | SELL | -0.71% | 49.76K | Oct 14 | View |
| Oct 14, 2021 | Mardi Dier | CFO & EXECUTIVE VICE PRESIDENT | -6.74K | $82.00 | -$552.52K | SELL | -14.81% | 38.76K | Oct 12 - Oct 14 | View |
| Sep 09, 2021 | Karah Parschauer | EVP AND GENERAL COUNSEL | 0.00 | $77.58 | -$338.56K | SELL-OPTIONS | 0.00% | 28.67K | Sep 08 | View |
| Sep 02, 2021 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | 0.00 | $77.55 | -$225.53K | SELL-OPTIONS | 0.00% | 38.77K | Sep 01 - Sep 02 | View |
| Jul 08, 2021 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -375.00 | $91.53 | -$34.32K | SELL | -1.46% | 25.33K | Jul 06 | View |
| Jun 23, 2021 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -1.01K | $94.82 | -$95.67K | SELL | -3.78% | 25.71K | Jun 19 - Jun 21 | View |
| Jun 11, 2021 | Karah Parschauer | EVP AND GENERAL COUNSEL | -1.33K | $100.00 | -$132.90K | SELL | -4.43% | 28.67K | Jun 10 | View |
| May 10, 2021 | Karl Dennis Huang | EVP & CHIEF TECH OPS OFFICER | -363.00 | $113.68 | -$41.27K | SELL | -0.89% | 40.51K | May 06 | View |
| May 10, 2021 | Karah Parschauer | EVP AND GENERAL COUNSEL | -313.00 | $113.67 | -$35.58K | SELL | -1.03% | 30.00K | May 06 | View |
| May 10, 2021 | Richard John Pinion | SEE REMARKS | -363.00 | $113.69 | -$41.27K | SELL | -0.72% | 50.12K | May 06 | View |
| May 10, 2021 | Alan Theodore Huizenga | SVP, CHIEF ACCOUNTING OFFICER | -142.00 | $113.67 | -$16.14K | SELL | -0.94% | 15.03K | May 06 | View |
| May 10, 2021 | Richard Thomas Kassberg | CBO & EVP | -363.00 | $113.69 | -$41.27K | SELL | -0.34% | 106.82K | May 06 | View |
| May 10, 2021 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -700.00 | $113.67 | -$79.57K | SELL | -2.55% | 26.72K | May 06 - May 07 | View |
| May 10, 2021 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | -364.00 | $113.67 | -$41.38K | SELL | -0.93% | 38.77K | May 06 | View |
| May 05, 2021 | EMIL KAKKIS | PRESIDENT & CEO | -30.00K | $107.80 | -$3.23M | SELL | -1.04% | 2.86M | May 03 | View |
| Apr 21, 2021 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -396.00 | $104.28 | -$41.29K | SELL | -1.42% | 27.42K | Apr 20 | View |
| Apr 19, 2021 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | 0.00 | $82.05 | -$270.45K | SELL-OPTIONS | 0.00% | 39.14K | Apr 15 | View |
| Mar 09, 2021 | Alan Theodore Huizenga | SVP, CONTROLLER AND PAO | -3.00K | $120.69 | -$362.07K | SELL | -18.13% | 13.54K | Mar 08 | View |
| Mar 03, 2021 | Richard Thomas Kassberg | CBO & EVP | 5.56K | $138.17 | -$631.71K | GRANT | 5.48% | 107.18K | Mar 01 | View |
| Mar 03, 2021 | Richard John Pinion | SEE REMARKS | 3.94K | $138.17 | -$856.38K | GRANT | 8.51% | 50.24K | Mar 01 | View |
| Mar 03, 2021 | Karah Parschauer | EVP AND GENERAL COUNSEL | 6.17K | $138.17 | -$548.53K | GRANT | 25.63% | 30.23K | Mar 01 | View |
| Mar 03, 2021 | Alan Theodore Huizenga | SVP, CONTROLLER AND PAO | 828.00 | $138.17 | -$101.14K | GRANT | 5.27% | 16.54K | Mar 01 | View |
| Mar 03, 2021 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | 6.96K | $138.17 | -$438.96K | GRANT | 33.37% | 27.81K | Mar 01 - Mar 02 | View |
| Mar 03, 2021 | Karl Dennis Huang | EVP & CHIEF TECH OPS OFFICER | 5.88K | $138.18 | -$587.96K | GRANT | 16.86% | 40.76K | Mar 01 | View |
| Mar 03, 2021 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | 5.59K | $138.18 | -$627.75K | GRANT | 16.67% | 39.14K | Mar 01 | View |
| Mar 03, 2021 | EMIL KAKKIS | PRESIDENT & CEO | -12.89K | $142.04 | -$6.58M | SELL | -0.56% | 2.29M | Mar 01 | View |
| Feb 23, 2021 | William Aliski | DIRECTOR | -1.00K | $123.43 | -$383.70K | SELL | -1.31% | 75.16K | Feb 19 - Feb 23 | View |
| Feb 03, 2021 | Erik Harris | EVP & CHIEF COMMERCIAL OFFICER | -2.52K | $74.69 | -$187.92K | SELL | -10.77% | 20.85K | Jun 03 | View |
| Feb 02, 2021 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | -2.24K | $140.36 | -$314.83K | SELL | -6.27% | 33.55K | Jan 30 | View |
| Jan 19, 2021 | Camille Bedrosian | EVP AND CHIEF MEDICAL OFFICER | 0.00 | $97.09 | -$2.10M | SELL-OPTIONS | 0.00% | 35.79K | Jan 15 | View |
| Jan 08, 2021 | Alan Theodore Huizenga | SVP, CONTROLLER AND PAO | 0.00 | $80.83 | -$478.60K | SELL-OPTIONS | 0.00% | 15.72K | Jan 07 | View |
| Jan 05, 2021 | EMIL KAKKIS | PRESIDENT & CEO | -30.00K | $136.90 | -$4.11M | SELL | -1.01% | 2.94M | Jan 04 | View |
| Nov 04, 2020 | EMIL KAKKIS | — | -30.00K | $96.82 | -$2.90M | SELL | -1.00% | 2.97M | Nov 02 | View |
| Nov 02, 2020 | Karah Parschauer | — | 0.00 | $77.31 | -$451.77K | OPTION EXERCISE | 0.00% | 24.06K | Oct 30 | View |
| Oct 30, 2020 | Karah Parschauer | — | 0.00 | $77.25 | -$4.41K | OPTION EXERCISE | 0.00% | 23.97K | Oct 28 | View |
| Oct 16, 2020 | Camille Bedrosian | — | -262.00 | $88.00 | -$23.06K | SELL | -0.73% | 35.79K | Oct 14 | View |
| Oct 16, 2020 | Karah Parschauer | — | -325.00 | $88.00 | -$28.60K | SELL | -1.34% | 23.97K | Oct 14 | View |
| Oct 16, 2020 | Richard Thomas Kassberg | CBO & EVP | -262.00 | $87.98 | -$23.05K | SELL | -0.26% | 101.48K | Oct 14 | View |
| Oct 16, 2020 | Erik Harris | — | -220.00 | $88.00 | -$19.36K | SELL | -0.93% | 23.37K | Oct 14 | View |
| Oct 16, 2020 | Richard John Pinion | — | -262.00 | $88.00 | -$23.06K | SELL | -0.56% | 46.30K | Oct 14 | View |
| Oct 16, 2020 | Karl Dennis Huang | — | -262.00 | $88.00 | -$23.06K | SELL | -0.75% | 34.70K | Oct 14 | View |
| Oct 16, 2020 | Alan Theodore Huizenga | — | -146.00 | $87.98 | -$12.85K | SELL | -0.88% | 16.44K | Oct 14 | View |
| Oct 16, 2020 | Shalini Sharp | — | -375.00 | $87.99 | -$33.00K | SELL | -0.38% | 97.81K | Oct 14 | View |
| Oct 13, 2020 | Richard John Pinion | — | -2.78K | $94.47 | -$262.63K | SELL | -5.63% | 46.56K | Oct 12 | View |
| Oct 13, 2020 | Karah Parschauer | — | 0.00 | $74.75 | -$405.00K | OPTION EXERCISE | 0.00% | 24.29K | Oct 08 | View |
| Oct 07, 2020 | Karah Parschauer | — | 0.00 | $69.22 | -$415.70K | OPTION EXERCISE | 0.00% | 24.29K | Oct 06 | View |
| Sep 24, 2020 | Karah Parschauer | — | 0.00 | $66.72 | -$365.70K | OPTION EXERCISE | 0.00% | 24.29K | Sep 23 | View |
| Sep 02, 2020 | EMIL KAKKIS | — | -30.00K | $82.63 | -$2.48M | SELL | -0.99% | 3.00M | Sep 01 | View |
| Aug 25, 2020 | William Aliski | — | 0.00 | $72.66 | -$139.15K | OPTION EXERCISE | 0.00% | 67.47K | Aug 21 | View |
| Aug 19, 2020 | Karah Parschauer | — | -2.37K | $71.47 | -$548.88K | OPTION EXERCISE | -8.89% | 24.29K | Aug 17 | View |
| Aug 19, 2020 | Shalini Sharp | — | -3.02K | $74.96 | -$572.55K | OPTION EXERCISE | -2.98% | 98.19K | Aug 17 | View |
| Aug 11, 2020 | CLAY SIEGALL | — | -9.75K | $56.09 | -$2.30M | OPTION EXERCISE | -79.27% | 2.55K | Aug 07 - Aug 10 | View |
| Jul 15, 2020 | EMIL KAKKIS | — | -40.00K | $85.35 | -$3.41M | SELL | -1.30% | 3.03M | Jul 13 | View |
| Jul 10, 2020 | Alan Theodore Huizenga | — | -638.00 | $56.00 | -$198.06K | OPTION EXERCISE | -3.70% | 16.58K | Jul 08 | View |
| Jul 08, 2020 | Matthew Fust | — | 0.00 | $55.50 | -$426.49K | OPTION EXERCISE | 0.00% | 13.55K | Jul 06 | View |
| Jul 06, 2020 | Matthew Fust | — | 0.00 | $53.00 | -$320.00K | OPTION EXERCISE | 0.00% | 13.55K | Jul 01 | View |
| Jul 06, 2020 | Alan Theodore Huizenga | — | -1.11K | $51.00 | -$179.99K | OPTION EXERCISE | -6.06% | 17.22K | Jul 01 | View |
| Jun 05, 2020 | Shalini Sharp | — | 0.00 | $61.31 | -$329.62K | OPTION EXERCISE | 0.00% | 101.21K | Jun 03 - Jun 04 | View |
| Jun 03, 2020 | William Aliski | — | -20.00K | $74.02 | -$1.48M | SELL | -18.46% | 88.35K | May 18 | View |
| May 27, 2020 | Alan Theodore Huizenga | — | -693.00 | $74.23 | -$51.44K | TAX | -3.64% | 18.33K | May 25 - May 26 | View |
| May 20, 2020 | William Aliski | — | 0.00 | $57.51 | -$257.10K | OPTION EXERCISE | 0.00% | 65.92K | May 18 | View |
| May 20, 2020 | Shalini Sharp | — | -2.39K | $70.62 | -$320.50K | OPTION EXERCISE | -2.30% | 101.56K | May 18 - May 19 | View |
| May 19, 2020 | Alan Theodore Huizenga | — | -961.00 | $46.00 | -$143.23K | OPTION EXERCISE | -4.81% | 19.02K | May 15 | View |
| May 19, 2020 | Matthew Fust | — | -1.88K | $75.00 | -$140.63K | SELL | -14.56% | 11.00K | May 18 | View |
| May 19, 2020 | Karah Parschauer | — | -2.72K | $74.72 | -$203.37K | SELL | -9.06% | 27.31K | May 18 | View |
| Apr 24, 2020 | Matthew Fust | — | -1.88K | $65.00 | -$121.88K | SELL | -12.71% | 12.88K | Apr 22 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.